(Q35853410)

10 August 2017

1 reference

title

Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children (English)

1 reference

10 August 2017

S K Obaro

1

1 reference

10 August 2017

D Pugatch

series ordinal

2

1 reference

10 August 2017

K Luzuriaga

series ordinal

3

1 reference

10 August 2017

publication date

1 August 2004

1 reference

Lancet Infectious Diseases

10 August 2017

published in

1 reference

10 August 2017

volume

4

1 reference

10 August 2017

issue

8

1 reference

10 August 2017

page(s)

510-518

1 reference

Paediatric hospital admissions at a South African urban regional hospital: the impact of HIV, 1992-1997.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

T cell activation and human immunodeficiency virus replication after influenza immunization of infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Factors controlling the turnover of T memory cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

B cell memory and the long-lived plasma cell

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Control of homeostasis of CD8+ memory T cells by opposing cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage phi X174 in asymptomatic HIV-1 infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Antigen dependent and independent mechanisms that sustain serum antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

A systematic comparison of methods to measure HIV-1 specific CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Beyond six colors: a new era in flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Antibody responses to bacterial toxoids in children infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Bacterial infections in human immunodeficiency virus-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Acellular pertussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

BCG: the challenge continues

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Immunological conditions of children with BCG disseminated infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Bacillus Calmette-Guérin infection after vaccination of human immunodeficiency virus-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

HIV-negative infants born to HIV-1 but not HIV-2-positive mothers fail to develop a Bacillus Calmette-Guérin scar

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Epidemiology of bloodstream infections in a bacille Calmette-Guérin-vaccinated pediatric population in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Vaccine-associated paralytic poliomyelitis and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Varicella-zoster virus infections in children infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Unsuspected varicella-zoster virus encephalitis in a child with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Immunization of HIV-infected children with varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Severe measles in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Maternally acquired immunity in newborns from women infected by the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

MMR vaccine in HIV-infected children -- potential hazards?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Measles and measles immunity in children infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Present status of measles and rubella immunization in the United States: A medical progress report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Increased risk of early measles in infants of human immunodeficiency virus type 1-seropositive mothers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

1 reference

7 January 2021

Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Pneumococcal and influenza immunization and human immunodeficiency virus load in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Rotavirus vaccine development for the prevention of severe diarrhea in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Chronic rotavirus infection in immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Extraintestinal rotavirus infections in children with immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Association of rotavirus and human immunodeficiency virus infection in children hospitalized with acute diarrhea, Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

HIV infection and isolated detection of anti-HBc

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Impaired response to hepatitis B vaccine in HIV infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Failure of the conjugate pneumococcal vaccine to prevent recurrent bacteremia in a child with human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

Herd immunity and herd protection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901106-5

7 January 2021

10.1016/S1473-3099(04)01106-5

Identifiers

DOI

1 reference

10 August 2017

1 reference